BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

437 related articles for article (PubMed ID: 16251196)

  • 1. Defective lysosomal arginine transport in juvenile Batten disease.
    Ramirez-Montealegre D; Pearce DA
    Hum Mol Genet; 2005 Dec; 14(23):3759-73. PubMed ID: 16251196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absence of Btn1p in the yeast model for juvenile Batten disease may cause arginine to become toxic to yeast cells.
    Vitiello SP; Wolfe DM; Pearce DA
    Hum Mol Genet; 2007 May; 16(9):1007-16. PubMed ID: 17341489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered arginine metabolism in the central nervous system (CNS) of the Cln3-/- mouse model of juvenile Batten disease.
    Chan CH; Ramirez-Montealegre D; Pearce DA
    Neuropathol Appl Neurobiol; 2009 Apr; 35(2):189-207. PubMed ID: 19284480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased expression of lysosomal acid phosphatase in CLN3-defective cells and mouse brain tissue.
    Pohl S; Mitchison HM; Kohlschütter A; van Diggelen O; Braulke T; Storch S
    J Neurochem; 2007 Dec; 103(6):2177-88. PubMed ID: 17868323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered gene expression in the eye of a mouse model for batten disease.
    Chattopadhyay S; Kingsley E; Serour A; Curran TM; Brooks AI; Pearce DA
    Invest Ophthalmol Vis Sci; 2004 Sep; 45(9):2893-905. PubMed ID: 15326100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. btn1, the Schizosaccharomyces pombe homologue of the human Batten disease gene CLN3, regulates vacuole homeostasis.
    Gachet Y; Codlin S; Hyams JS; Mole SE
    J Cell Sci; 2005 Dec; 118(Pt 23):5525-36. PubMed ID: 16291725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel interactions of CLN3 protein link Batten disease to dysregulation of fodrin-Na+, K+ ATPase complex.
    Uusi-Rauva K; Luiro K; Tanhuanpää K; Kopra O; Martín-Vasallo P; Kyttälä A; Jalanko A
    Exp Cell Res; 2008 Sep; 314(15):2895-905. PubMed ID: 18621045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Action of BTN1, the yeast orthologue of the gene mutated in Batten disease.
    Pearce DA; Ferea T; Nosel SA; Das B; Sherman F
    Nat Genet; 1999 May; 22(1):55-8. PubMed ID: 10319861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of Batten disease with the yeast Saccharomyces cerevisiae.
    Pearce DA; Sherman F
    Mol Genet Metab; 1999 Apr; 66(4):314-9. PubMed ID: 10191120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A role in vacuolar arginine transport for yeast Btn1p and for human CLN3, the protein defective in Batten disease.
    Kim Y; Ramirez-Montealegre D; Pearce DA
    Proc Natl Acad Sci U S A; 2003 Dec; 100(26):15458-62. PubMed ID: 14660799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retinal pathology and function in a Cln3 knockout mouse model of juvenile Neuronal Ceroid Lipofuscinosis (batten disease).
    Seigel GM; Lotery A; Kummer A; Bernard DJ; Greene ND; Turmaine M; Derksen T; Nussbaum RL; Davidson B; Wagner J; Mitchison HM
    Mol Cell Neurosci; 2002 Apr; 19(4):515-27. PubMed ID: 11988019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protracted course of juvenile ceroid lipofuscinosis associated with a novel CLN3 mutation (p.Y199X).
    Sarpong A; Schottmann G; Rüther K; Stoltenburg G; Kohlschütter A; Hübner C; Schuelke M
    Clin Genet; 2009 Jul; 76(1):38-45. PubMed ID: 19489875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CLN3L, a novel protein related to the Batten disease protein, is overexpressed in Cln3-/- mice and in Batten disease.
    Narayan SB; Pastor JV; Mitchison HM; Bennett MJ
    Brain; 2004 Aug; 127(Pt 8):1748-54. PubMed ID: 15240430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Localization and processing of CLN3, the protein associated to Batten disease: where is it and what does it do?
    Pearce DA
    J Neurosci Res; 2000 Jan; 59(1):19-23. PubMed ID: 10658181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel CLN3 mutation predicted to cause complete loss of protein function does not modify the classical JNCL phenotype.
    Kwon JM; Rothberg PG; Leman AR; Weimer JM; Mink JW; Pearce DA
    Neurosci Lett; 2005 Oct; 387(2):111-4. PubMed ID: 16087292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cln3-mutations underlying juvenile neuronal ceroid lipofuscinosis cause significantly reduced levels of Palmitoyl-protein thioesterases-1 (Ppt1)-protein and Ppt1-enzyme activity in the lysosome.
    Appu AP; Bagh MB; Sadhukhan T; Mondal A; Casey S; Mukherjee AB
    J Inherit Metab Dis; 2019 Sep; 42(5):944-954. PubMed ID: 31025705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CLN3 protein regulates lysosomal pH and alters intracellular processing of Alzheimer's amyloid-beta protein precursor and cathepsin D in human cells.
    Golabek AA; Kida E; Walus M; Kaczmarski W; Michalewski M; Wisniewski KE
    Mol Genet Metab; 2000 Jul; 70(3):203-13. PubMed ID: 10924275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene symbol: CLN3. Disease: Juvenile neuronal ceroid lipofuscinosis (Batten disease).
    Leman AR; Pearce DA; Rothberg PG
    Hum Genet; 2005 May; 116(6):544. PubMed ID: 15991331
    [No Abstract]   [Full Text] [Related]  

  • 19. Gene symbol: CLN3. Disease: juvenile neuronal ceroid lipofuscinosis (Batten disease).
    Leman AR; Pearce DA; Rothberg PG
    Hum Genet; 2005 Feb; 116(3):236. PubMed ID: 15818814
    [No Abstract]   [Full Text] [Related]  

  • 20. The subcellular location of the yeast Saccharomyces cerevisiae homologue of the protein defective in the juvenile form of Batten disease.
    Croopnick JB; Choi HC; Mueller DM
    Biochem Biophys Res Commun; 1998 Sep; 250(2):335-41. PubMed ID: 9753630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.